Amylyx Pharmaceuticals, Inc.
AMLX
$9.25
$0.829.73%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -11.39% | 15.62% | -24.70% | -24.34% | -17.01% |
| Total Receivables | -32.36% | -45.14% | -68.40% | -58.70% | -79.71% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -50.23% | -4.91% | 35.54% | -28.16% | -23.33% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -13.53% | 14.10% | -22.76% | -24.93% | -20.42% |
|
|
|||||
| Total Current Assets | -13.53% | 14.10% | -22.76% | -24.93% | -20.42% |
| Net Property, Plant & Equipment | 201.98% | -24.16% | -22.54% | -16.86% | -25.72% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -0.62% | -0.68% | -23.56% | 60.52% | -1.16% |
| Total Assets | -11.42% | 13.45% | -22.77% | -24.52% | -20.43% |
|
|
|||||
| Total Accounts Payable | -31.52% | 63.66% | 97.65% | -69.99% | -76.90% |
| Total Accrued Expenses | 44.73% | -49.61% | -52.53% | -19.60% | -7.54% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -36.97% | -30.50% | -23.02% | -16.76% | 2.47% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 19.47% | -36.87% | -47.31% | -23.07% | -23.52% |
|
|
|||||
| Total Current Liabilities | 19.47% | -36.87% | -47.31% | -23.07% | -23.52% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1,519.88% | -29.37% | -22.18% | -22.93% | -44.14% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 46.34% | -36.75% | -47.04% | -23.07% | -23.83% |
|
|
|||||
| Common Stock & APIC | 0.87% | 9.39% | 0.89% | 0.91% | 1.28% |
| Retained Earnings | -6.45% | -5.92% | -6.60% | -14.65% | -17.16% |
| Treasury Stock & Other | -- | -- | -114.35% | 760.82% | -25.97% |
| Total Common Equity | -16.65% | 22.25% | -16.02% | -24.92% | -19.46% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -16.65% | 22.25% | -16.02% | -24.92% | -19.46% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -16.65% | 22.25% | -16.02% | -24.92% | -19.46% |
|
|
|||||